<DOC>
	<DOCNO>NCT02993835</DOCNO>
	<brief_summary>Determination fractional iron absorption bouillon fortify 3 label iron compound .</brief_summary>
	<brief_title>Iron Bioavailability From Fortified Food</brief_title>
	<detailed_description>This single center trial single-blind subject , control , fully randomize crossover design 22 healthy female age 18-40 year old . Subjects attend 8 visit . At screen ( V0 ) , 3 consecutive feeding day ( V1-V3 ) , 14 day last stable isotope intake 3 consecutive feeding day ( V4-V6 ) , 14 day last stable isotope intake blood sampling ( V7 ) .</detailed_description>
	<mesh_term>Iron</mesh_term>
	<criteria>1 . Women age 1840 year old 2 . Healthy , base medical screen visit include blood formula 3 . Normal BMI age ( 18.525.0 kg/m2 ) 4 . Weight le 65 kg 5 . Able understand sign write informed consent prior trial entry 6 . Informed consent sign 1 . Anemia polycythemia respectively evidence one follow criterion standard blood formula : number erythrocytes 4.0 5.8 1012/l Hb 120160 g/l Ht 3555 % . Subjects outside range exclude . 2 . Significant blood loss past 6 month ( i.e . trauma , major surgery , blood donation cause appreciate investigator ) . 3 . Serum ferritin 80 Âµg/L range . As result , hemochromatosis exclude . 4 . Any therapy medication take infectious inflammatory disease past two week . 5 . Relevant digestive ( intestinal , gastric , hepatic pancreatic ) , renal , metabolic disease , determine screen visit selfreport subject . 6 . Diagnosed food allergy . 7 . Pregnancy ( test plasma screen ) and/or lactation . 8 . History cancer within past year . 9 . Significant weight loss last 3 month ( 10 % ) 10 . Any medication supplement may impact erythrocyte , Hb Ht ( opinion investigator ) . 11 . Iron supplementation therapy perfusion last three month . 12 . Smokers ( &gt; 5 cigarette per day ) . 13 . Have high alcohol consumption ( 2 drinks/day ) . 14 . Consumption illicit drug ( anamnesis ) . 15 . Subject hierarchical link investigator coinvestigators . 16 . Subject expect comply treatment study procedure . 17 . Currently participate participate another clinical trial past month prior begin study . 18 . Subjects willing and/or able comply schedule visit requirement study protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>